Book Value per Share: FSD Pharma (HUGE)

FSD Pharma Inc. focuses on developing precision medications to combat severe neurodegenerative pathologies. The absolute book value per share confirms this strategy, and the value of 0.30 shows the latest metric reading. Patent protection for small molecules creates high barriers to entry for competitors, while the implementation of robotic screening and software robots accelerates the processing of clinical data.

fsdpharma.com (HUGE): Share Book Value from 07/04/2022 to 08/15/2024

fsdpharma.com - analytical breakdowns and key metrics (HUGE)

- price and consensus price forecast:

Stock Price FSD Pharma Inc.|HUGE - Analyst Target Range

- market capitalization data:

Market Capitalization FSD Pharma Inc.|HUGE - Total Enterprise Value

- book capitalization data:

Net Assets per Single Share FSD Pharma|HUGE - Net Asset Value|Market Capitalization to Book Value Ratio fsdpharma.com|HUGE - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital FSD Pharma Inc.|HUGE - Long-Term Debt to Capital|Short-Term Debt to Equity FSD Pharma|HUGE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio FSD Pharma Inc.

Fundamental company valuation:FSD Pharma Inc. - HUGE

For the investor, the asset quality assessment of FSD Pharma Inc. (HUGE) is based on an analysis of equity allocated to each issued security. The book value per share trend reflects the residual value of the company's assets after all liabilities are settled, which, given the biotech startup's total absence of debt, confirms its high financial autonomy and the robust protection of its capital structure.

Competitors of FSD Pharma Inc. (HUGE)